ADC THERAPEUTICS SA (ADCT)
CH0499880968 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 278.60M | 326.40M | 466.50M | 439.20M | 115.60M | |||
| Receivables | 25.18M | 74.40M | 30.60M | 1.40M | 1.10M | |||
| Inventories | 16.18M | 18.60M | 11.10M | N/A | N/A | |||
| Other Current Assets | 16.33M | 26.70M | 17.00M | 9.90M | 5.90M | |||
| Total Current Assets | 336.29M | 446.00M | 525.20M | 450.50M | 122.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.13M | 10.00M | 11.20M | 4.80M | 6.30M | |||
| Investments And Advances | 1.65M | 31.20M | 41.20M | 47.90M | N/A | |||
| Intangibles | N/A | 14.40M | 13.60M | 10.20M | 8.40M | |||
| Other Non-Current Assets | 711.00K | 27.70M | 26.70M | 400.00K | 400.00K | |||
| Total Non-Current Assets | 18.49M | 83.20M | 92.80M | 63.20M | 15.10M | |||
| TOTAL ASSETS | 354.78M | 529.20M | 618.00M | 513.70M | 137.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.47M | 13.60M | 7.60M | 4.60M | 1.10M | |||
| Accrued Expenses | 39.06M | 16.30M | 16.10M | 12.10M | 5.70M | |||
| Accounts Payable | 15.57M | 12.40M | 12.10M | 5.30M | 3.30M | |||
| Other Current Liabilities | 13.04M | 56.70M | 38.20M | 18.50M | 9.80M | |||
| Total Current Liabilities | 67.67M | 99.00M | 73.90M | 40.40M | 19.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 416.30M | 316.20M | 312.80M | 37.20M | 3.90M | |||
| Other Non-Current Liabilities | 19.06M | 25.30M | 65.10M | 100.50M | 2.70M | |||
| Total Non-Current Liabilities | 435.36M | 341.40M | 378.00M | 137.80M | 6.60M | |||
| TOTAL LIABILITIES | 503.03M | 440.40M | 451.90M | 178.20M | 26.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.34B | -925.00M | -822.20M | -652.10M | -443.10M | |||
| Additional Paid In Capital | 1.18B | 1.01B | 981.80M | 981.10M | 549.90M | |||
| Common Shares | 7.31M | 7.30M | 6.40M | 6.30M | 4.40M | |||
| Treasury Stock | -541.00K | -700.00K | -100.00K | 0.00 | -100.00K | |||
| Other Shareholders' Equity | -93.00K | -400.00K | 200.00K | 200.00K | 100.00K | |||
| Shares Outstanding | 82.29M | 80.60M | 76.80M | 76.70M | 76.70M | |||
| Tangible Book Value per Share | -1.80 | 0.92 | 1.99 | 4.24 | 1.34 | |||
| Total Shareholders' Equity | -148.25M | 88.70M | 166.10M | 335.50M | 111.20M | |||
| TOTAL LIABILITIES AND EQUITY | 354.78M | 529.20M | 618.00M | 513.70M | 137.70M | |||
| Statistics | ||||||||
| Debt/Equity | -2.81 | 3.56 | 1.88 | 0.11 | 0.04 | |||
| Current Ratio | 4.97 | 4.51 | 7.11 | 11.15 | 6.16 | |||
| Return On Assets (ROA) | -67.66% | -29.44% | -37.22% | -47.95% | -84.60% | |||
| Return On Equity (ROE) | N/A | -175.65% | -138.47% | -73.41% | -104.77% | |||
All data in USD